Literature DB >> 17315990

Flux (2): comparison of molecular mutation and crossover operators for ligand-based de novo design.

Uli Fechner1, Gisbert Schneider.   

Abstract

We implemented a fragment-based de novo design algorithm for a population-based optimization of molecular structures. The concept is grounded on an evolution strategy with mutation and crossover operators for structure breeding. Molecular building blocks were obtained from the pseudo-retrosynthesis of a collection of pharmacologically active compounds following the RECAP principle. The influence of mutation and crossover on the course of optimization was assessed in redesign studies using known drugs as template structures. A topological atom-pair descriptor grounded on potential pharmacophore points was used as a molecular descriptor, and the Manhattan distance between the template and candidate molecules served as a fitness function. Exclusive use of the crossover operator yielded few unique compounds and often resulted in premature convergence of the optimization process, whereas exclusive use of the mutation operator resulted in diverse high-quality structures. Combinations of crossover and mutation yielded the overall best results. The majority of the designed structures exhibit a chemically reasonable architecture; chiral centers are rare, and unfavorable connections of building blocks are infrequent. We conclude that this fragment-based design principle is suited as an idea generator for the automated design of novel leadlike molecules.

Mesh:

Substances:

Year:  2007        PMID: 17315990     DOI: 10.1021/ci6005307

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  6 in total

1.  The concept of template-based de novo design from drug-derived molecular fragments and its application to TAR RNA.

Authors:  Andreas Schüller; Marcel Suhartono; Uli Fechner; Yusuf Tanrikulu; Sven Breitung; Ute Scheffer; Michael W Göbel; Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2007-12-07       Impact factor: 3.686

2.  Molecular shape and medicinal chemistry: a perspective.

Authors:  Anthony Nicholls; Georgia B McGaughey; Robert P Sheridan; Andrew C Good; Gregory Warren; Magali Mathieu; Steven W Muchmore; Scott P Brown; J Andrew Grant; James A Haigh; Neysa Nevins; Ajay N Jain; Brian Kelley
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

3.  DOGS: reaction-driven de novo design of bioactive compounds.

Authors:  Markus Hartenfeller; Heiko Zettl; Miriam Walter; Matthias Rupp; Felix Reisen; Ewgenij Proschak; Sascha Weggen; Holger Stark; Gisbert Schneider
Journal:  PLoS Comput Biol       Date:  2012-02-16       Impact factor: 4.475

4.  Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag.

Authors:  Tairan Liu; Misagh Naderi; Chris Alvin; Supratik Mukhopadhyay; Michal Brylinski
Journal:  J Chem Inf Model       Date:  2017-04-04       Impact factor: 4.956

5.  Towards systematic exploration of chemical space: building the fragment library module in molecular property diagnostic suite.

Authors:  Anamika Singh Gaur; Lijo John; Nandan Kumar; M Ram Vivek; Selvaraman Nagamani; Hridoy Jyoti Mahanta; G Narahari Sastry
Journal:  Mol Divers       Date:  2022-08-04       Impact factor: 3.364

6.  Enhancing reaction-based de novo design using a multi-label reaction class recommender.

Authors:  Gian Marco Ghiandoni; Michael J Bodkin; Beining Chen; Dimitar Hristozov; James E A Wallace; James Webster; Valerie J Gillet
Journal:  J Comput Aided Mol Des       Date:  2020-02-28       Impact factor: 3.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.